Posted by Michael Wonder on 30 Sep 2021
Landmark PBS listings to reduce the cost of medicines for Australians
30 September 2021 - From 1 October 2021, Australians with multiple sclerosis, multiple myeloma, macular degeneration and keratitis will have access to new and expanded medicines listed on the PBS, reducing the cost of treatment for patients and their families.
Kesimpta (ofatumumab) will be listed on the PBS to treat patients with relapsing-remitting multiple sclerosis.
